Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Faculty of Health Sciences

Honours Biology and Pharmacology Co-Op Program

Lectureships

The Denis Crankshaw Lectureships

Introduction

Each year, as part of Biology and Pharmacology course work, students from the graduating class have the opportunity to plan a lectureship. A guest speaker is invited to address topics related to Pharmacology. Students choose a speaker based on their interests and are in charge of every aspect of the lectureship from inviting the speaker, to advertising and running the event itself.

Posters

  1. Early Life Exposures to Drug. March 23, 2023. (Dr. Shinya Ito, Clinical Scientist and Staff Physician, Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children (SickKids), Toronto)
  2. Integrating Scale in Mental Health Drug Research. (March 29, 2022. Jean Martin Beaulieu, Associate Professor, Department of Pharmacology & Toxicology, University of Toronto)
  3. HIV-Infection of the brain and novel pharmacological treatment (March 25, 2021. Dr. Reina Bendayan. Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, ON)
  4. Nuclear hormone receptors as drug targets to treat metabolic diseases: new approaches and potential therapies (March 12, 2020. Dr. Carolyn Cummins, Faculty member within Leslie Dan Faculty of Pharmacy, University of Toronto, ON)
  5. Drug Discovery: The Importance of Picking the Right Target (March 28, 2019. Jason Uslaner, PhD., Executive Director, Neuroscience, Pain and Symptomatics, Merck Pharmaceuticals in WestPoint, PA)
  6. Beta 2-Adrengeric Receptor Signalling in Asthma: Persistence, Naiveté, Occam’s Razor, and Popper’s Falsification (March 2018. Richard Bond, PhD., Professor of Pharmacology, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston)
  7. The Diverse Clinical Applications and Mechanisms of Action of “Antipsychotic” Drugs. (March 2017. Herbert Y Meltzer, M.D., Professor of Psychiatry, Pharmacology, and Physiology at Northwestern University, Feinberg School of Medicine)
  8. Molecular Genetic and Pharmacological Approaches to Understanding nAChRs, Nicotine and their Role in Behaviour (March 10th, 2016. Marina Picciotto, PhD., Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, or Neuroscience and Pharmacology; Deputy Chair for Basic Science Research, Dept. of Psychiatry, Yale University)
  9. What Academics Bring to Drug Discovery (March 5th, 2014. Richard Neubig, M.D. PhD., Chair of the Department of Pharmacology and Toxicology, Michigan State University)
  10. Transforming Discovery into Opportunity: the Centre for Drug Research and Development (CDRD) Resources to Translate Academic Research to Novel Therapies (February 12, 2013. Murray Webb, Head, Pharmacology & Toxicology, The Centre for Drug Research and Development, Vancouver, British Columbia)
  11. The evolution of ‘efficacy’ as a pharmacological concept in drug discovery (February 14, 2012. Terry Kenakin, PhD., Department of Pharmacology, University of North Carolina School of Medicine)
  12. Making medicine: Why is it so difficult? (January 26, 2011. Patrick Vallance PhD., GlaxoSmithKline Inc. Vice President Medicines Discovery and Development.)
  13. Beta-blockers and beta-agonists in asthma: Unravelling a paradox? (March 4, 2010. Richard Bond PhD., Professor, Department of Pharmacological and Pharmaceutical Sciences, University of Houston.)
  14. G-protein coupled receptors as oligomeric signaling machines; Insights into the molecular basis of drug efficacy. (January 14, 2009. Michel Bouvier PhD., Professor of Biochemistry, Institute for Research in Immunology and Cancer, Université de Montréal.)
  15. The 1st Lectureship (Guest speaker Dr. William Catterall.)